Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H G Westenberg

Showing results (41-50 of 96) with videos related to

Pageof 10
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 1, 1992
Psychopharmacological treatment of social phobia: clinical and biochemical effects of brofaromine, a selective MAO-A inhibitorI M van Vliet, J A den Boer, H G Westenberg
Psychopharmacology|September 1, 1996
Effects of the 5-HT1A receptor agonist flesinoxan in panic disorderI M van Vliet, H G Westenberg, J A den Boer
Journal of Neurochemistry|November 1, 1986
The dopamine metabolite 3-methoxytyramine is not a suitable indicator of dopamine release in the rat brainA G Vulto, H G Westenberg, L B Meijer, et al.
Acta Neuropsychiatrica|March 10, 2016
The clinical significance of atypical antipsychoticsJ A Boer, H G Westenberg, J W Louwerens, et al.
Journal of Affective Disorders|May 18, 2001
Characteristics of patients with social phobia and their treatment in specialized clinics for anxiety disorders in the NetherlandsA E Dingemans, I M van Vliet, J Couvée, et al.
Biological Psychiatry|March 15, 2000
Serotonergic blunting to meta-chlorophenylpiperazine (m-CPP) highly correlates with sustained childhood abuse in impulsive and autoaggressive female borderline patientsT Rinne, H G Westenberg, J A den Boer, et al.
Journal of Neurochemistry|June 1, 1996
Flesinoxan dose-dependently reduces extracellular 5-hydroxytryptamine (5-HT) in rat median raphe and dorsal hippocampus through activation of 5-HT1A receptorsF J Bosker, T Y de Winter, A A Klompmakers, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 1, 1995
Endocrine and cardiovascular responses to a series of graded physical and psychological stress stimuli in healthy volunteersF W Kok, H G Westenberg, J H Thijssen, et al.
Psychopharmacology|February 1, 1995
Chronic treatment with fluvoxamine by osmotic minipumps fails to induce persistent functional changes in central 5-HT1A and 5-HT1B receptors, as measured by in vivo microdialysis in dorsal hippocampus of conscious ratsF J Bosker, K E van Esseveldt, A A Klompmakers, et al.
Veterinary and Human Toxicology|January 1, 1979
An unusual case of carbamazepine poisoning with a near-fatal relapse after two daysR A de Zeeuw, H G Westenberg, E Vander Kleijn, et al.
Pageof 10

Showing results (41-50 of 96) with videos related to

Sort By:
Pageof 10
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 1, 1992
Psychopharmacological treatment of social phobia: clinical and biochemical effects of brofaromine, a selective MAO-A inhibitorI M van Vliet, J A den Boer, H G Westenberg
Psychopharmacology|September 1, 1996
Effects of the 5-HT1A receptor agonist flesinoxan in panic disorderI M van Vliet, H G Westenberg, J A den Boer
Journal of Neurochemistry|November 1, 1986
The dopamine metabolite 3-methoxytyramine is not a suitable indicator of dopamine release in the rat brainA G Vulto, H G Westenberg, L B Meijer, et al.
Acta Neuropsychiatrica|March 10, 2016
The clinical significance of atypical antipsychoticsJ A Boer, H G Westenberg, J W Louwerens, et al.
Journal of Affective Disorders|May 18, 2001
Characteristics of patients with social phobia and their treatment in specialized clinics for anxiety disorders in the NetherlandsA E Dingemans, I M van Vliet, J Couvée, et al.
Biological Psychiatry|March 15, 2000
Serotonergic blunting to meta-chlorophenylpiperazine (m-CPP) highly correlates with sustained childhood abuse in impulsive and autoaggressive female borderline patientsT Rinne, H G Westenberg, J A den Boer, et al.
Journal of Neurochemistry|June 1, 1996
Flesinoxan dose-dependently reduces extracellular 5-hydroxytryptamine (5-HT) in rat median raphe and dorsal hippocampus through activation of 5-HT1A receptorsF J Bosker, T Y de Winter, A A Klompmakers, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 1, 1995
Endocrine and cardiovascular responses to a series of graded physical and psychological stress stimuli in healthy volunteersF W Kok, H G Westenberg, J H Thijssen, et al.
Psychopharmacology|February 1, 1995
Chronic treatment with fluvoxamine by osmotic minipumps fails to induce persistent functional changes in central 5-HT1A and 5-HT1B receptors, as measured by in vivo microdialysis in dorsal hippocampus of conscious ratsF J Bosker, K E van Esseveldt, A A Klompmakers, et al.
Veterinary and Human Toxicology|January 1, 1979
An unusual case of carbamazepine poisoning with a near-fatal relapse after two daysR A de Zeeuw, H G Westenberg, E Vander Kleijn, et al.
Pageof 10